79610 Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices 

SECURITY CLASSIFICATION: 

Unclassified. 

SYSTEM LOCATION: 

Federal Trade Commission, 600 

Pennsylvania Avenue NW, Washington, 

DC 20580. For other locations where 

records may be maintained or accessed, 

see Appendix III (Locations of FTC 

Buildings and Regional Offices), 

available on the FTC’s website at 

https://www.ftc.gov/about-ftc/foia/foiareading-rooms/privacy-act-systems and 

at 87 FR 57698 (Sept. 21, 2022). 

SYSTEM MANAGER(S): 

Office of the Secretary, Records 

Management Division, Federal Trade 

Commission, 600 Pennsylvania Avenue 

NW, Washington, DC 20580, email: 

SORNs@ftc.gov. 

AUTHORITY FOR MAINTENANCE OF THE SYSTEM: 

Federal Trade Commission Act, 15 

U.S.C. 41 et seq. 

PURPOSE(S) OF THE SYSTEM: 

To provide staff with the ability to 

search for and access copies of agency 

documents needed for legal and 

economic research activities of the 

Commission (e.g., internal memoranda, 

economic reports, other agency work 

product); to provide FTC staff 

processing Freedom of Information Act 

or other disclosure requests with the 

ability to search for and access copies of 

potentially responsive documents 

outlining the actions and considerations 

of the Commission, individual 

Commissioners, and the staff; to provide 

the ability, once the automated system 

is fully implemented, to electronically 

manage the writing, editing, storage, 

retrieval and disposal of such 

documents (e.g., memoranda, 

correspondence), and to provide for 

additional document management 

functions, if any. 

CATEGORIES OF INDIVIDUALS COVERED BY THE

SYSTEM: 

Individuals who have written 

documents contained in Commission 

files, and other individuals whose 

names or other personally identifying 

data are used to search and retrieve 

documents from the system. 

CATEGORIES OF RECORDS IN THE SYSTEM: 

Name of author and documents 

written by that individual; names or 

other data about other individuals by 

which documents in the system are 

searched and retrieved; finding aids or 

document indexes. Records in this 

system may duplicate records included 

in other FTC systems of records. See, 

e.g., FTC–I–1 (Nonpublic Investigational 

and Other Nonpublic Legal Program 

Records–FTC), FTC–I–6 (Public 

Records–FTC). 

RECORD SOURCE CATEGORIES: 

FTC employees and others who 

submit documents to the Commission. 

ROUTINE USES OF RECORDS MAINTAINED IN THE

SYSTEM, INCLUDING CATEGORIES OF USERS AND

THE PURPOSES OF SUCH USES: 

Records in this system may be 

disclosed to contractors in connection 

with document processing, storage, 

disposal and similar records 

management and retrieval activities. 

For other ways that the Privacy Act 

permits the FTC to use or disclose 

system records outside the agency, see 

Appendix I (Authorized Disclosures and 

Routine Uses Applicable to All FTC 

Privacy Act Systems of Records), 

available on the FTC’s website at 

https://www.ftc.gov/about-ftc/foia/foiareading-rooms/privacy-act-systems and 

at 83 FR 55541, 55542–55543 (Nov. 6, 

2018). 

POLICIES AND PRACTICES FOR STORAGE OF

RECORDS: 

Older records are stored on electronic 

and non-electronic formats. The system 

also comprises one or more structured 

databases using commercial software 

applications to search, retrieve, and 

manage records stored electronically. 

POLICIES AND PRACTICES FOR RETRIEVAL OF

RECORDS: 

Indexed by author of the document, or 

other data fields or codes. 

POLICIES AND PRACTICES FOR RETENTION AND

DISPOSAL OF RECORDS: 

Records are retained and destroyed in 

accordance with schedules and 

procedures issued or approved by the 

National Archives and Records 

Administration. 

ADMINISTRATIVE, TECHNICAL, AND PHYSICAL

SAFEGUARDS: 

Access is restricted to agency 

personnel and contractors whose 

responsibilities require access. Paper or 

other non-digital records are stored in 

secure offsite storage or lockable file 

cabinets or offices. Access to electronic 

records is controlled by ‘‘user ID’’ and 

password combination, and/or rolebased access controls, and/or other 

appropriate electronic access or network 

controls (e.g., firewalls). FTC buildings 

are guarded and monitored by security 

personnel, cameras, ID checks, and 

other physical security measures. 

RECORD ACCESS PROCEDURES: 

See § 4.13 of the FTC’s Rules of 

Practice, 16 CFR 4.13. For additional 

guidance, see also Appendix II (How to 

Make A Privacy Act Request), available 

on the FTC’s website at https://

www.ftc.gov/about-ftc/foia/foia-readingrooms/privacy-act-systems and at 73 FR 

33592, 33634 (June 12, 2008). 

CONTESTING RECORD PROCEDURES: 

See § 4.13 of the FTC’s Rules of 

Practice, 16 CFR 4.13. For additional 

guidance, see also Appendix II (How to 

Make A Privacy Act Request), available 

on the FTC’s website at https://

www.ftc.gov/about-ftc/foia/foia-readingrooms/privacy-act-systems at 73 FR 

33592, 33634 (June 12, 2008). 

NOTIFICATION PROCEDURES: 

See § 4.13 of the FTC’s Rules of 

Practice, 16 CFR 4.13. For additional 

guidance, see also Appendix II (How to 

Make A Privacy Act Request), available 

on the FTC’s website at https://

www.ftc.gov/about-ftc/foia/foia-readingrooms/privacy-act-systems at 73 FR 

33592, 33634 (June 12, 2008). 

EXEMPTIONS PROMULGATED FOR THE SYSTEM: 

Records contained in this system that 

have been placed on the FTC public 

record are available upon request or, 

where applicable, made available 

online. See FTC–I–6 (Public Records– 

FTC). However, pursuant to 5 U.S.C. 

552a(k)(2), records in this system, which 

reflect records that are contained in 

other systems of records that are 

designated as exempt, are exempt from 

the requirements of subsections (c)(3), 

(d), (e)(1), (e)(4)(G), (H), (I), and (f) of 5 

U.S.C. 552a. See § 4.13(m) of the FTC 

Rules of Practice, 16 CFR 4.13(m). 

HISTORY: 

87 FR 964–974 (January 7, 2022) 

73 FR 33591–33634 (June 12, 2008). 

* * * * * 

Joel Christie, 

Acting Secretary. 

[FR Doc. 2024–22391 Filed 9–27–24; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2024–0072] 

Meeting of the Advisory Committee on 

Immunization Practices 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice and request for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices 79611 

Prevention (CDC) announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. Time will be available for public 

comment. 

DATES: The meeting will be held on 

October 23, 2024, from 8 a.m. to 5:30 

p.m., EDT and October 24, 2024, from 

8 a.m. to 5:30 p.m., EDT, (times subject 

to change); see the ACIP website for 

updates: https://www.cdc.gov/vaccines/ 

acip/index.html). 

Written comments must be received 

between October 4–18, 2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0072, by either of the methods listed 

below. CDC does not accept comments 

by email. 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Ms. Stephanie Thomas, ACIP 

Meeting, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H24–8, Atlanta, Georgia 

30329–4027. Attn: Docket No. CDC– 

2024–0072. 

Instructions: All submissions received 

must include the Agency name and 

docket number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

The meeting will be webcast live via 

the World Wide Web. The webcast link 

can be found on the ACIP website at 

https://www.cdc.gov/vaccines/acip/ 

index.html. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, Committee 

Management Specialist, Advisory 

Committee on Immunization Practices, 

National Center for Immunization and 

Respiratory Diseases, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop H24–8, 

Atlanta, Georgia 30329–4027. 

Telephone: (404) 639–8836; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Advisory Committee on 

Immunization Practices (ACIP) is 

charged with advising the Director, 

Centers for Disease Control and 

Prevention (CDC), on the use of 

immunizing agents. In addition, under 

42 U.S.C. 1396s, the Committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under applicable provisions of the 

Affordable Care Act and Section 2713 of 

the Public Health Service Act, 

immunization recommendations of 

ACIP that have been approved by the 

Director, CDC, and appear on CDC 

immunization schedules generally must 

be covered by applicable health plans. 

Matters to be Considered: The agenda 

will include discussions on 

chikungunya vaccines, COVID–19 

vaccines, cytomegalovirus (CMV) 

vaccine, Human papillomavirus (HPV) 

vaccines, influenza vaccines, 

meningococcal vaccines, mpox 

vaccines, pneumococcal vaccines, 

Respiratory Syncytial Virus (RSV) 

vaccines for adults, RSV vaccines for 

maternal and pediatric populations, and 

the adult and child/adolescent 

immunization schedules. 

Recommendation votes are scheduled 

for COVID–19 vaccines, meningococcal 

vaccines, pneumococcal vaccines, RSV 

vaccines for adults, and the adult and 

child/adolescent immunization 

schedules. A Vaccines for Children 

(VFC) vote is scheduled for influenza 

vaccines and meningococcal vaccines. 

Agenda items are subject to change as 

priorities dictate. For more information 

on the meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web. For more information on ACIP, 

please visit the ACIP website: https://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near-duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on October 4–18, 2024. 

Written comments must be received by 

October 18, 2024. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. Oral 

public comment will occur before any 

scheduled votes, including all votes 

relevant to the ACIP’s Affordable Care 

Act and Vaccines for Children Program 

roles. Priority will be given to 

individuals who submit a request to 

make an oral public comment before the 

meeting according to the procedures 

below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the October 23–24, 

2024, ACIP meeting must submit a 

request at https://www.cdc.gov/ 

vaccines/acip/meetings/index.html 

between October 4–18, 2024, and no 

later than 11:59 p.m., EDT, October 18, 

2024, according to the instructions 

provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by October 21, 2024. To accommodate 

the significant interest in participation 

in the oral public comment session of 

ACIP meetings, each speaker will be 

limited to three minutes, and each 

speaker may speak only once per 

meeting. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–22357 Filed 9–27–24; 8:45 am] 

BILLING CODE 4163–18–P 


ddrumheller on DSK120RN23PROD with NOTICES1